Morocco Misses Out On Record German Medical Cannabis Imports Friday, 19 February 2021
Morocco, Europe’s largest cannabis supplier, is falling behind against countries that have legalized cannabis as German imports grow. Even amid the COVID-19 crisis, Germany’s medical cannabis imports hit a record high in the fourth quarter of 2020. The country imported nearly 10,000 kilograms of legal medical cannabis in 2020.
While traditionally Morocco has supplied 70% of Europe’s demand, all of Germany’s legal imports were supplied by countries that have legalized their cannabis industry. Whereas much of the illegal market in EUrope continues to rely on untaxed exports from Morocco, the legal market is being supplied by Canada, the Netherlands, Uruguay, Spain, Australia and Israel.
Share this article
PANGYO, GYEONGGI PROVINCE, Korea, Jan. 29, 2021 /PRNewswire/
SK Biopharmaceuticals announced that the European Medicines Agency s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of cenobamate for the adjunctive treatment of focal-onset (partial-onset) seizures with or without secondary generalization in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least two anti-seizure medications (ASMs). The European Commission (EC), which is authorized to approve medicines in the European Union, is expected to issue its decision within approximately 67 days of receipt of the CHMP opinion.
SK Biopharmaceuticals and Arvelle Therapeutics entered into a licensing agreement in 2019 for Arvelle to commercialize SK Biopharmaceuticals cenobamate in Europe. Cenobamate has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of partial-onset (focal-ons
ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults
January 29, 2021 12:20 ET | Source: Arvelle Therapeutics Arvelle Therapeutics
Positive CHMP opinion is an important milestone for Arvelle Therapeutics and cenobamate
When approved, cenobamate will provide new hope in helping adult patients with uncontrolled focal epilepsy move closer to the goal of seizure reduction and seizure freedom
ZUG, Switzerland, Jan. 29, 2021 (GLOBE NEWSWIRE) Arvelle Therapeutics, an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from central nervous system (CNS) disorders, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of cenobamate for the
06:51 AM
From this month, public hospitals in Germany can apply for government funding for projects to boost digital health, cybersecurity, and IT infrastructure.
Under the Hospital Future Act (KHZG), which came into force in September 2020, public hospitals will receive a share of €4.3 billion for digital health innovation.
The German federal government (Bundestag) will make €3 billion available to the KHZF through the liquidity reserve of the health fund with an additional €1.3 billion to be provided through co-funding by the federal states and hospital operators themselves. At least 15% of the funding requested must be used to improve IT security.
Hospitals can submit their projected measures to the authorities in their members state before the end of September this year. Funding will be decided subject to regional investment priorities. Compliance with data protection regulation is also a criterion for eligibility.
Global Cannabis Market Expected to Reach USD 52,995 4 Million by 2027 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.